Literature DB >> 169139

Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.

A Du Moulin, J Schultz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169139     DOI: 10.1007/bf02358828

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Mechanism of stimulation of Ca2+ plus Mg2+ -dependent phospodiesterase from rat cerebral cortex by the modulator protein and Ca2+.

Authors:  Y Teshima; S Kakiuchi
Journal:  Biochem Biophys Res Commun       Date:  1974-01-23       Impact factor: 3.575

3.  Effects of therapeutic agents on cyclic AMP metabolism in vitro.

Authors:  I Weinryb; M Chasin; C A Free; D N Harris; H Goldenberg; I M Michel; V S Paik; M Phillips; S Samaniego; S M Hess
Journal:  J Pharm Sci       Date:  1972-10       Impact factor: 3.534

4.  Separation of multiple molecular forms of cyclic adenosine-3',5'-monophosphate phosphodiesterase in rat cerebellum by polyacrylamide gel electrophoresis.

Authors:  P Uzunov; B Weiss
Journal:  Biochim Biophys Acta       Date:  1972-09-19

5.  Effects of phenothiazine tranquilizers on the cyclic 3',5'-adenosine monophosphate system of rat brain.

Authors:  P Uzunov; B Weiss
Journal:  Neuropharmacology       Date:  1971-11       Impact factor: 5.250

6.  Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate.

Authors:  G Pöch
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

7.  Multiple forms of cyclic 3',5'-AMP phosphodiesterase of rat cerebrum and cloned astrocytoma and neuroblastoma cells.

Authors:  P Uzunov; H M Shein; B Weiss
Journal:  Neuropharmacology       Date:  1974-05       Impact factor: 5.250

8.  Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity.

Authors:  J A Beavo; N L Rogers; O B Crofford; J G Hardman; E W Sutherland; E V Newman
Journal:  Mol Pharmacol       Date:  1970-11       Impact factor: 4.436

9.  Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety.

Authors:  B Beer; M Chasin; D E Clody; J R Vogel
Journal:  Science       Date:  1972-04-28       Impact factor: 47.728

10.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

View more
  1 in total

1.  Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.

Authors:  H Wachtel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.